New medications on the positive list starting from July, the Health Insurance Fund (HIF) director Sasho Klekovski told a press briefing on Friday.
“At last, Clexane and Fraxiparine will be available in pharmacies, plus one more. These are medications anticoagulants, in general, for several different populations. Let’s say from acute cases, postoperatively, to prevent coagulation after severe interventions. For example, after hip replacement, they are used in the elderly population with heart problems,” the director noted.
In response to a media question, he said that this has become a widespread practice in our country with pregnant women, and the indications for Clexane do not say anywhere that pregnant women should take it. Pregnant women with certain indications should take it, not pregnant women per se. When it comes to this medication, there was no approval in Malmed for such use in the indications.
The HIF head was asked why every woman who undergoes in vitro fertilization must be prescribed Clexane by default.
“In the case of pathological pregnancies, we are now planning a special meeting with the Gynecology and Obstetrics Clinic, because it is completely unclear what they decide is a pathological pregnancy, because two-thirds of pregnancies are already pathological, which is abnormal. I mean, two-thirds cannot be pathology,” Klekovski responded.
